[go: up one dir, main page]

JPH03127709A - Hard tissue-filling paste having mitigated stimulation to living body and production thereof - Google Patents

Hard tissue-filling paste having mitigated stimulation to living body and production thereof

Info

Publication number
JPH03127709A
JPH03127709A JP1267696A JP26769689A JPH03127709A JP H03127709 A JPH03127709 A JP H03127709A JP 1267696 A JP1267696 A JP 1267696A JP 26769689 A JP26769689 A JP 26769689A JP H03127709 A JPH03127709 A JP H03127709A
Authority
JP
Japan
Prior art keywords
acid
hard tissue
aqueous solution
tissue filling
kneaded product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1267696A
Other languages
Japanese (ja)
Other versions
JP2817966B2 (en
Inventor
Masaya Sumida
政哉 澄田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pentax Corp
Original Assignee
Asahi Kogaku Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Kogaku Kogyo Co Ltd filed Critical Asahi Kogaku Kogyo Co Ltd
Priority to JP1267696A priority Critical patent/JP2817966B2/en
Publication of JPH03127709A publication Critical patent/JPH03127709A/en
Application granted granted Critical
Publication of JP2817966B2 publication Critical patent/JP2817966B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Materials For Medical Uses (AREA)
  • Dental Preparations (AREA)

Abstract

(57)【要約】本公報は電子出願前の出願データであるた
め要約のデータは記録されません。
(57) [Summary] This bulletin contains application data before electronic filing, so abstract data is not recorded.

Description

【発明の詳細な説明】 「利用分野」 本発明は、医科用あるいは歯科用の硬組織補填材用練和
物に関する。
DETAILED DESCRIPTION OF THE INVENTION Field of Application The present invention relates to a kneaded material for medical or dental hard tissue prosthesis materials.

「従来技術及びその問題点」 α−リン酸三カルシウムなど、ある種のリン酸カルシウ
ムには水和凝結性があり、クエン酸などの酸水溶液を用
いると、硬化はより速やかに進行することから、この素
材を医科用あるいは歯科用硬組織補填材として用いる試
みが、近年、非常に盛んになってきており、多数の報告
がなされている(例えば、特開昭59−88351号、
同59182263号、同60−36404号、同61
−191606号、同61−234868号、同61−
236644号、同61−270249号、同61−7
2363号、同61−833/19号公報など)。
"Prior art and its problems" Some types of calcium phosphates, such as α-tricalcium phosphate, have hydration-setting properties, and when an aqueous acid solution such as citric acid is used, curing proceeds more rapidly. Attempts to use materials as medical or dental hard tissue prosthesis materials have become very popular in recent years, and many reports have been made (for example, Japanese Patent Application Laid-Open No. 88351/1983;
No. 59182263, No. 60-36404, No. 61
-191606, 61-234868, 61-
No. 236644, No. 61-270249, No. 61-7
No. 2363, Publication No. 61-833/19, etc.).

しかしながら、これらの材料は、生体外で完全に硬化さ
せてから生体内に埋入する場合には、その硬化体を補填
部分の形状に適合させる加工が煩雑であり、他方、従来
の医科・歯科用各種セメントのように未硬化状態、すな
わち、可塑性のある状態で埋入する場合には、補填部分
の形状に適合させるのは極めて容易であるが、生体内に
埋入すると、未反応の酸が溶出し、生体組織に刺激を与
え、炎症を引き起こすという問題があった。
However, when these materials are completely cured outside the body and then implanted in the body, the processing to adapt the hardened material to the shape of the replacement part is complicated, and on the other hand, conventional medical and dental When implanted in an unhardened state, that is, in a plastic state, such as various types of cement, it is extremely easy to adapt it to the shape of the replacement part, but when implanted in a living body, unreacted acid There was a problem in that it elutes, irritates living tissues, and causes inflammation.

「発明の目的」 本発明の目的は、完全に硬化する前の可塑性のある状態
でリン酸カルシウム系練和物を生体内に埋入した際の生
体組織への刺激を軽減した硬組織補填用練和物及びその
製造方法を提供することにある。
``Object of the Invention'' The purpose of the present invention is to create a hard tissue filling compound that reduces irritation to living tissue when a calcium phosphate compound is implanted in a living body in a plastic state before completely hardening. The objective is to provide products and methods of manufacturing them.

「発明の構成」 本発明による硬組織補填用練和物は、リン酸カルシウム
系粉剤と酸水溶液との練和物の表面に水と混和しない生
分解性物質の薄膜を有することを特徴とする。
"Structure of the Invention" The hard tissue filling kneaded product according to the present invention is characterized by having a thin film of a biodegradable substance that is immiscible with water on the surface of the kneaded product of a calcium phosphate powder and an acid aqueous solution.

この硬組織補填用練和物は、本発明方法によればリン酸
カルシウム系粉剤と酸水溶液とを混練することにより生
成した練和物を水と混和しない生分解性物質の液に浸漬
し、練和物の表面に薄膜を形成することによって製造さ
れる。
According to the method of the present invention, this kneaded material for hard tissue filling is obtained by immersing a kneaded material produced by kneading a calcium phosphate powder and an acid aqueous solution in a solution of a biodegradable substance that is immiscible with water, and then kneading it. Manufactured by forming a thin film on the surface of an object.

リン酸カルシウム系粉剤と酸水溶液とを混練すると、硬
化体が得られるが、本発明においては完全に硬化する前
の可塑性を持つ状態で水と混和しない生分解性物質の液
中に浸漬する。
A hardened product is obtained by kneading a calcium phosphate powder and an acid aqueous solution, but in the present invention, the material is immersed in a liquid of a biodegradable material that is immiscible with water in a plastic state before being completely hardened.

本発明に用いるリン酸カルシウム系粉剤は、リン酸カル
シウム系硬化体の製造に用いられる任意の粉剤であって
よく、具体的には、α−リン酸三カルシウム及び/又は
リン酸四カルシウムを必須成分として含むものである。
The calcium phosphate-based powder used in the present invention may be any powder used for producing a calcium phosphate-based hardened product, and specifically, contains α-tricalcium phosphate and/or tetracalcium phosphate as an essential component. .

粉剤は、上記必須成分の他に、場合によりさらにハイド
ロキシアパタイトあるいはβ−リン酸三カルシウムを含
んでいてもよいが、α−リン酸三カルシウム及び/又は
リン酸四カルシウムを全体の1/3以上含むことを必要
とする。これらの成分が1/3未満であると、組成物が
充分に硬化しない。ハイドロキシアパタイトあるいはβ
−リン酸三カルシウムを添加すると、硬化体の強度が改
善されるため、これらを含む粉剤を用いるのが好ましい
。また、これらの粉剤成分は、完全には純粋でなくても
よく、合成中に生じた少量の不純物を含んでいてもよい
In addition to the above-mentioned essential ingredients, the powder may further contain hydroxyapatite or β-tricalcium phosphate, but α-tricalcium phosphate and/or tetracalcium phosphate accounts for 1/3 or more of the total. Requires inclusion. If the content of these components is less than ⅓, the composition will not be sufficiently cured. Hydroxyapatite or β
- Addition of tricalcium phosphate improves the strength of the cured product, so it is preferable to use a powder containing tricalcium phosphate. Additionally, these powder components may not be completely pure and may contain small amounts of impurities generated during synthesis.

一方、硬化液として使用する酸水溶液は、無機及び有機
の各種の酸を溶解して含むものであってよい。酸として
は、例えばリン酸などの無機酸、又は酢酸、乳酸、クエ
ン酸、リンゴ酸、マロン酸、コハク酸、グルタル酸、酒
石酸、ポリアクリル酸などの有機酸が挙げられる。これ
らの酸を好ましくは25重量%以上、より好ましくは2
5〜55重量%の酸濃度の水溶液として用いる。酸性水
溶液の酸濃度が25重量%未満であると、粉剤と混合す
ることによって得られる硬化体が所望の強度を示さない
On the other hand, the acid aqueous solution used as the curing liquid may contain dissolved various inorganic and organic acids. Examples of acids include inorganic acids such as phosphoric acid, or organic acids such as acetic acid, lactic acid, citric acid, malic acid, malonic acid, succinic acid, glutaric acid, tartaric acid, and polyacrylic acid. These acids are preferably 25% by weight or more, more preferably 2% by weight or more.
It is used as an aqueous solution with an acid concentration of 5 to 55% by weight. If the acid concentration of the acidic aqueous solution is less than 25% by weight, the cured product obtained by mixing with the powder will not exhibit the desired strength.

本発明において、単IIi類、少糖類、多糖類、糖アル
コール及び多価アルコールのうちの1種以上を酸水溶液
に添加剤として加えることができる。
In the present invention, one or more of monoIIIi, oligosaccharides, polysaccharides, sugar alcohols and polyhydric alcohols can be added to the acid aqueous solution as an additive.

これらの添加剤は、硬化反応を穏和に進行させたり、混
線時に成形性を向上させる作用する。
These additives act to moderate the curing reaction and improve moldability when cross-wired.

使用しうる単糖類としては、例えばグルコース、フルク
トース等が挙げられ、少糖類としては、例えばサッカロ
ース、マルトース、ラクトース、ラフィノース等が挙げ
られる。また、多糖類を添加すると、硬化反応が著しく
緩和となり、ガム状の練和物を生じるため、欠損部に補
填する場合に好ましいものである。使用しうる多糖類と
しては、例えばカルボキシメチルキチン、グリコールキ
チン、プルラン、ペクチン、高メトキシ化ペクチン、ヒ
アルロン酸及びキトサンが挙げられ、特にキトサンが好
ましい。なお、本明細書において、「キトサン」とは、
部分的又は完全に脱アセチル化されたキチンを意味する
ものとする。キトサンの脱アセチル化度及びカルボキシ
メチルキチン及びグリコールキチンの置換度は、特に制
限されない。
Examples of monosaccharides that can be used include glucose and fructose, and examples of oligosaccharides include saccharose, maltose, lactose, and raffinose. Furthermore, when polysaccharides are added, the curing reaction is significantly relaxed and a gummy kneaded product is produced, which is preferable when filling in defective areas. Polysaccharides that can be used include, for example, carboxymethyl chitin, glycol chitin, pullulan, pectin, highly methoxylated pectin, hyaluronic acid and chitosan, with chitosan being particularly preferred. In addition, in this specification, "chitosan" means
Partially or fully deacetylated chitin is meant. The degree of deacetylation of chitosan and the degree of substitution of carboxymethyl chitin and glycol chitin are not particularly limited.

糖アルコールとしては、例えばソルビット、マンニット
、キシリット等、さらに多価アルコールとしては、例え
ばエチレングリコール等のグリコール類、グリセリン等
が挙げられる。
Examples of sugar alcohols include sorbitol, mannitol, xylit, etc., and examples of polyhydric alcohols include glycols such as ethylene glycol, glycerin, and the like.

これらの添加剤の使用量は、状況により適宜決定するこ
とができるが、あまり少ないと、添加効果が発揮されな
い。−船釣には、単糖類、少糖類、糖アルコール及び多
価アルコールの濃度は、好ましくは合計で40重量%以
下、より好ましくは合計で30重量%以下とする。これ
らの添加量が40重量%を越えると、これらの添加剤が
酸水溶液に溶解し難くなる。他方、多糖類は、0.05
重量%以上の濃度で酸水溶液に添加するのが好ましい。
The amount of these additives to be used can be appropriately determined depending on the situation, but if the amount is too small, the effect of the addition will not be exhibited. - For boat fishing, the concentration of monosaccharides, oligosaccharides, sugar alcohols and polyhydric alcohols is preferably at most 40% by weight in total, more preferably at most 30% by weight in total. When the amount added exceeds 40% by weight, these additives become difficult to dissolve in the acid aqueous solution. On the other hand, polysaccharides are 0.05
It is preferable to add it to the acid aqueous solution at a concentration of % by weight or more.

上記のような硬化反応に関与する添加剤の他に硬組織補
填材に添加することが提案されている各種の金属酸化物
、抗生物質、タンニン酸、タンニン酸誘導体、モノフル
オロリン酸ナトリウム、クエン酸ナトリウム、コラーゲ
ンなどを添加することができる。
In addition to the additives involved in the hardening reaction mentioned above, various metal oxides, antibiotics, tannic acid, tannic acid derivatives, sodium monofluorophosphate, and citric acid are proposed to be added to hard tissue prosthetic materials. Sodium acid, collagen, etc. can be added.

本発明においては、上記のように調製された粉剤と液剤
とを混練することによって硬化体を製造する。その際、
粉剤(P)と液剤(L)の混練比は、液剤に対する粉剤
の配合量(P/L)が重量比で0.4〜2.7となるよ
うにするのが好ましい。
In the present invention, a cured product is produced by kneading the powder and liquid prepared as described above. that time,
The kneading ratio of the powder agent (P) and the liquid agent (L) is preferably such that the mixing ratio of the powder agent to the liquid agent (P/L) is 0.4 to 2.7 in terms of weight ratio.

ここで、この比が0.4未満であると、固形分が少ない
ため、得られる硬化体の強度が弱くなり、方、2.7を
超えると、粉剤と液剤との均一な練和が困難となる。
If this ratio is less than 0.4, the strength of the resulting cured product will be weak due to the small solid content, while if it exceeds 2.7, it will be difficult to uniformly mix the powder and liquid. becomes.

本発明においては、上記のような粉剤と液剤とを混練し
、まだ可塑性のある状態の練和物を水と混和しない生分
解製物質の液に浸漬する。可塑性のある状態及びその持
続時間は用いる粉剤及び液剤の種類、濃度、粉液比によ
って異なる。
In the present invention, the above-mentioned powder and liquid are kneaded, and the kneaded product, which is still plastic, is immersed in a liquid of a biodegradable substance that is immiscible with water. The plastic state and its duration vary depending on the type, concentration, and powder/liquid ratio of the powder and liquid used.

本発明において、練和物の表面に薄膜を形成するため用
いる、水と混和しない生分解性物質としては、常温で液
体であるか又は加熱により液化する生体為害性のない物
質であれば各種のものを使用することができ、5具体的
には、例えば不飽和脂肪酸、植物性あるいは動物性油脂
、台底ポリマーあるいはコポリマーなどが挙げられる。
In the present invention, the water-immiscible biodegradable substance used to form a thin film on the surface of the kneaded product may be any of a variety of substances that are liquid at room temperature or non-toxic to living organisms that liquefy when heated. Specific examples include unsaturated fatty acids, vegetable or animal fats, and base polymers or copolymers.

不飽和脂肪酸としては、パルミトレイン酸系、オレイン
酸系、リノール酸系、α−リルン酸系のものがある。ま
た、植物性油脂としては、オリーブ油、ゴマ油など、動
物性油脂としては、肝油などが挙げられる。さらに、台
底ポリマーあるいはコポリマーとしては、例えばL−乳
酸・δ−バレロラクトンコポリマーなどが生分解性であ
ることが知られており、本発明に用いることができる。
Examples of unsaturated fatty acids include palmitoleic acid, oleic acid, linoleic acid, and α-lylunic acid. Further, examples of vegetable oils and fats include olive oil and sesame oil, and examples of animal oils and fats include liver oil and the like. Further, as the base polymer or copolymer, for example, L-lactic acid/δ-valerolactone copolymer is known to be biodegradable and can be used in the present invention.

本発明においては、水と混和しない生分解性物質は、練
和物の表面に薄膜を形威し、練和物が硬化するまで、練
和物中の未反応の酸が体液によって溶解・溶出されるの
を防止すればよいので、使用する物質は生体内での代謝
排泄の早いものが好ましい。また、浸漬時間は、使用す
る生分解性物質によって左右されるが、通常、2秒前後
あれば充分である。
In the present invention, the water-immiscible biodegradable substance forms a thin film on the surface of the kneaded material, and unreacted acids in the kneaded material are dissolved and eluted by body fluids until the kneaded material is hardened. Therefore, it is preferable that the substance used be one that is quickly metabolized and excreted in the body. The immersion time depends on the biodegradable material used, but usually around 2 seconds is sufficient.

「発明の実施例」 次に、本発明を実施例に基づいてさらに詳しく説明する
が、本発明はこれに限定されるものではない。
"Examples of the Invention" Next, the present invention will be described in more detail based on Examples, but the present invention is not limited thereto.

実施例1 水酸化カルシウムスラリーとリン酸水溶液を用いて公知
の湿式法でハイドロキシアパタイトスラリーを合成した
。得られたスラリーを噴霧乾燥して粉末化した後、減圧
下(約10””Pa) 1200°Cで加熱したところ
、ハイドロキシアパタイト粉末は完全に熱分解し、α〜
リン酸三カルシウムとリン酸四カルシウムとの混合物が
得られた。これを粉剤とし、この粉剤2gにグルコース
15%とキトサン(共和油脂工業■製、商品名フローナ
ンクN)1%を含む45%クエン酸水溶液1gを液剤と
して混練し、まだ、可塑性のある状態(混練開始3分後
)の練和物をlOmHのオリーブ油(小堺製薬■製、日
本薬局方適合品)に2秒間浸漬してから取り出した。
Example 1 A hydroxyapatite slurry was synthesized by a known wet method using a calcium hydroxide slurry and an aqueous phosphoric acid solution. After the obtained slurry was spray-dried and powdered, it was heated at 1200°C under reduced pressure (approximately 10''Pa), and the hydroxyapatite powder was completely thermally decomposed and α ~
A mixture of tricalcium phosphate and tetracalcium phosphate was obtained. This was made into a powder, and 2 g of this powder was kneaded with 1 g of a 45% citric acid aqueous solution containing 15% glucose and 1% chitosan (manufactured by Kyowa Yushi Kogyo ■, trade name Flonanc N) as a liquid. After 3 minutes from the start), the kneaded product was immersed in 10mH of olive oil (manufactured by Kosakai Pharmaceutical ■, product compliant with the Japanese Pharmacopoeia) for 2 seconds, and then taken out.

得られた浸漬練和物からの酸の溶出状態を検討■ するため、練和物を茅留水中に投入し、5分後にpHを
測定したところ、pnは約5.9であり、参照に用いた
蒸留水(約6.0)からのpl+低下はほとんど認めら
れなかった。
In order to examine the state of acid elution from the obtained soaked kneaded product, the kneaded product was put into distilled water and the pH was measured after 5 minutes.The pn was approximately 5.9, which was used as a reference. Almost no decrease in pl+ was observed from the distilled water used (approximately 6.0).

実施例2 オリーブ油の代わりにゴマ浦(小堺製薬■製、日本薬局
方適合品)を用いた他は、実施例1と同様の操作を行な
い、表面にゴマ油の薄膜を有する練和物を製造した。こ
れを蒸留水中に投入したところ、5分後の水のpl+は
約5.9であり、蒸留水(pH6,0)からのpl+低
下はほとんど認められなかった。
Example 2 A kneaded product having a thin film of sesame oil on the surface was produced by carrying out the same operation as in Example 1, except that sesame ura (manufactured by Kosakai Pharmaceutical ■, product compliant with the Japanese Pharmacopoeia) was used instead of olive oil. . When this was poured into distilled water, the pl+ of the water after 5 minutes was about 5.9, and almost no decrease in pl+ was observed from distilled water (pH 6.0).

比較例 練和物をオリーブ油に浸漬しない以外は、実施例1と同
様の操作を行ったところ、p17は約4.8を示し、p
l+低下が認められた。これは、練和物から未反応のク
エン酸が溶出しているものと考えられる。
Comparative Example The same operation as in Example 1 was performed except that the kneaded product was not immersed in olive oil, and p17 was about 4.8.
A decrease in l+ was observed. This is considered to be due to unreacted citric acid being eluted from the kneaded product.

「発明の効果コ 本発明による練和物は、生体内に未硬化状態で2 埋入しても、酸を溶出しないので、生体への刺激が著し
く軽減されており、可塑状態での埋入できるという利点
を活かして骨などの硬組織補填材として好適に使用する
ことができる。
``Effects of the Invention: Even if the kneaded product according to the present invention is implanted in a living body in an uncured state, it does not elute acid, so stimulation to the living body is significantly reduced, and it can be implanted in a plastic state. Taking advantage of this advantage, it can be suitably used as a hard tissue replacement material such as bone.

Claims (1)

【特許請求の範囲】 1、リン酸カルシウム系粉剤と酸水溶液との練和物の表
面に水と混和しない生分解性物質の薄膜を有することを
特徴とする生体への刺激を軽減した硬組織補填用練和物
。 2、水と混和しない生分解性物質が常温で液体又は加熱
により液化する生体為害性のない物質である請求項1記
載の硬組織補填用練和物。 3、水と混和しない生分解性物質が不飽和脂肪酸、植物
性あるいは動物性油脂、合成ポリマー又は合成コポリマ
ーである請求項2記載の硬組織補填用練和物。 4、リン酸カルシウム系粉剤がα−リン酸三カルシウム
及び/又はリン酸四カルシウムを必須成分として含むも
のである請求項1記載の硬組織補填用練和物。 5、酸水溶液がリン酸などの無機酸又は酢酸、乳酸、ク
エン酸、リンゴ酸、マロン酸、コハク酸、グルタル酸、
酒石酸、ポリアクリル酸などの有機酸の水溶液である請
求項1記載の硬組織補填用練和物。 6、酸水溶液が単糖類、少糖類、多糖類、糖アルコール
及び多価アルコールのうちの1種以上を含む請求項5記
載の硬組織補填用練和物。 7、リン酸カルシウム系粉剤と酸水溶液とを混練するこ
とにより生成した練和物を水と混和しない生分解性物質
の液に浸漬し、練和物の表面に薄膜を形成することを特
徴とする生体への刺激を軽減した硬組織補填用練和物の
製造方法。 8、水と混和しない生分解性物質が常温で液体又は加熱
により液化する生体為害性のない物質である請求項7記
載の硬組織補填用練和物の製造方法。 9、リン酸カルシウム系粉剤がα−リン酸三カルシウム
及び/又はリン酸四カルシウムを必須成分として含むも
のである請求項7記載の硬組織補填用練和物の製造方法
。 10、酸水溶液がリン酸などの無機酸又は酢酸、乳酸、
クエン酸、リンゴ酸、マロン酸、コハク酸、グルタル酸
、酒石酸、ポリアクリル酸などの有機酸の水溶液である
請求項7記載の硬組織補填用練和物の製造方法。 11、酸水溶液が単糖類、少糖類、多糖類、糖アルコー
ル及び多価アルコールのうちの1種以上を含む請求項1
0記載の硬組織補填用練和物の製造方法。
[Scope of Claims] 1. A hard tissue filling material that reduces irritation to living organisms, characterized by having a thin film of a biodegradable substance that is immiscible with water on the surface of a kneaded product of a calcium phosphate powder and an acid aqueous solution. Mixture. 2. The hard tissue filling compound according to claim 1, wherein the biodegradable substance that is immiscible with water is a liquid at room temperature or a non-toxic substance that liquefies when heated. 3. The hard tissue filling compound according to claim 2, wherein the water-immiscible biodegradable substance is an unsaturated fatty acid, a vegetable or animal oil, a synthetic polymer, or a synthetic copolymer. 4. The kneaded material for hard tissue filling according to claim 1, wherein the calcium phosphate powder contains α-tricalcium phosphate and/or tetracalcium phosphate as an essential component. 5. The acid aqueous solution is an inorganic acid such as phosphoric acid, or acetic acid, lactic acid, citric acid, malic acid, malonic acid, succinic acid, glutaric acid,
The kneaded material for hard tissue filling according to claim 1, which is an aqueous solution of an organic acid such as tartaric acid or polyacrylic acid. 6. The hard tissue filling kneaded product according to claim 5, wherein the acid aqueous solution contains one or more of monosaccharides, oligosaccharides, polysaccharides, sugar alcohols, and polyhydric alcohols. 7. A biomaterial characterized by immersing a kneaded product produced by kneading a calcium phosphate powder and an acid aqueous solution in a liquid of a biodegradable substance that is immiscible with water to form a thin film on the surface of the kneaded product. A method for producing a hard tissue filling compound that reduces irritation to the skin. 8. The method for producing a hard tissue replacement compound according to claim 7, wherein the biodegradable substance that is immiscible with water is a liquid at room temperature or a non-toxic substance that liquefies when heated. 9. The method for producing a kneaded product for hard tissue filling according to claim 7, wherein the calcium phosphate powder contains α-tricalcium phosphate and/or tetracalcium phosphate as an essential component. 10. The acid aqueous solution is an inorganic acid such as phosphoric acid, acetic acid, lactic acid,
The method for producing a hard tissue filling kneaded product according to claim 7, which is an aqueous solution of an organic acid such as citric acid, malic acid, malonic acid, succinic acid, glutaric acid, tartaric acid, or polyacrylic acid. 11. Claim 1 wherein the acid aqueous solution contains one or more of monosaccharides, oligosaccharides, polysaccharides, sugar alcohols, and polyhydric alcohols.
A method for producing a kneaded material for hard tissue filling according to 0.
JP1267696A 1989-10-13 1989-10-13 Hard tissue replenishing kneaded material with reduced irritation to living body and method for producing the same Expired - Fee Related JP2817966B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP1267696A JP2817966B2 (en) 1989-10-13 1989-10-13 Hard tissue replenishing kneaded material with reduced irritation to living body and method for producing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1267696A JP2817966B2 (en) 1989-10-13 1989-10-13 Hard tissue replenishing kneaded material with reduced irritation to living body and method for producing the same

Publications (2)

Publication Number Publication Date
JPH03127709A true JPH03127709A (en) 1991-05-30
JP2817966B2 JP2817966B2 (en) 1998-10-30

Family

ID=17448270

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1267696A Expired - Fee Related JP2817966B2 (en) 1989-10-13 1989-10-13 Hard tissue replenishing kneaded material with reduced irritation to living body and method for producing the same

Country Status (1)

Country Link
JP (1) JP2817966B2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7621959B2 (en) 2000-10-24 2009-11-24 Cryolife, Inc. Methods for the in situ formation of a bioprosthetic device, particularly vertebral disc bioprosthetics
US8057818B2 (en) 2000-11-07 2011-11-15 Cryolife, Inc. Methods of making expandable foam-like biomaterials

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7621959B2 (en) 2000-10-24 2009-11-24 Cryolife, Inc. Methods for the in situ formation of a bioprosthetic device, particularly vertebral disc bioprosthetics
US7621954B2 (en) 2000-10-24 2009-11-24 Cryolife, Inc. In situ bioprosthetic filler and methods, particularly for in situ formation of vertebral disc bioprosthetics
US7896920B2 (en) 2000-10-24 2011-03-01 Cryolife, Inc. In situ bioprosthetic filler and method, particularly for the in situ formation of vertebral disc bioprosthetics
US8057818B2 (en) 2000-11-07 2011-11-15 Cryolife, Inc. Methods of making expandable foam-like biomaterials
US8071124B2 (en) 2000-11-07 2011-12-06 Cryolife, Inc. Methods of using expandable foam-like biomaterials

Also Published As

Publication number Publication date
JP2817966B2 (en) 1998-10-30

Similar Documents

Publication Publication Date Title
US6214048B1 (en) Bone substitute product and method of producing the same
JP3559265B2 (en) Compositions for implantation into human and animal bodies
US6616742B2 (en) Process for preparing a paste from calcium phosphate cement
CH632158A5 (en) BONE REPLACEMENT, BONE COMPOSITE OR PROSTHESE ANCHORING MATERIAL.
DE3542972A1 (en) PHARMACADEPOT
DE68915265T2 (en) MEDICAL AND DENTAL NETWORKABLE MATERIAL.
DE19853832A1 (en) Calcium phosphate cements containing polyalkenoic acids
JP4215884B2 (en) Calcium phosphate cement and calcium phosphate cement composition
KR20080055782A (en) Compositions and methods for pain relief after surgery
US5980625A (en) Calcium phosphate composition and a setting solution therefor
JP2817966B2 (en) Hard tissue replenishing kneaded material with reduced irritation to living body and method for producing the same
JP3965249B2 (en) Calcium phosphate cement and calcium phosphate cement composition
CS235108B1 (en) Hemostatic mass
JPH02275812A (en) Liquid agent for hardened calcium phosphate and hardened material produced by using the agent
JPH03261643A (en) curable composition
JP2544075B2 (en) Method for producing cured body for medical and dental treatment
JPH0793941B2 (en) Manufacturing method of biological hard tissue repair material
JPH03112843A (en) Hydraulic calcium phosphate cement composition
JP3338534B2 (en) Medical and dental curable materials
JP4319280B2 (en) Calcium phosphate cement powder and calcium phosphate cement composition
JPH0331470B2 (en)
JPS61236644A (en) Calcium phosphate hardenable composition
JP3423951B2 (en) Calcium phosphate hardened powder
JP4116791B2 (en) Curing time control method of hydration hardening type calcium phosphate paste
JP2544073B2 (en) Medical and dental hardening cement

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees